Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Anhorn Medicines Co. Ltd.

Clinical trials sponsored by Anhorn Medicines Co. Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New drug candidate AH-008 takes first step toward easing chemotherapy nerve pain Results expected Sep 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New drug candidate AH-008 takes first step toward easing chemotherapy nerve pain

Knowledge-focused Recruiting now

This early-stage trial tests the safety and tolerability of a single dose of AH-008, a potential treatment for chemotherapy-induced peripheral neuropathy (nerve damage). Healthy adults aged 18 to 65 receive either AH-008 or a placebo by intravenous infusion. The study monitors si…

Phase 1 • Sponsor: AnHorn Medicines Co. Ltd. • Aim: Knowledge-focused

Last updated Jul 31, 2026 00:00 UTC